Subscribe To Our Free Newsletter |
Prices can’t go down further in APIs or it will turn unviable for new entrants: Laurus Labs CEO
“If you look at the current nine months financials, the ARV APIs and formulation put together contributed only 35% of revenue came from ARVs. It used to be 85% during actual times but now it is 35% and we do hope the ARV revenues contribution will be similar to what we have seen in this current financial year.”